PortfoliosLab logoPortfoliosLab logo
ISIN
US4333131039
IPO Date
May 22, 2025

Highlights

Market Cap
$4.82B
Enterprise Value
$4.64B
EPS (TTM)
-$6.30
Total Revenue (TTM)
$646.34M
Gross Profit (TTM)
$522.22M
EBITDA (TTM)
-$514.46M
Year Range
$30.08 - $62.18
Target Price
$56.88
ROA (TTM)
-70.02%
ROE (TTM)
-456.88%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

HNGE Performance Chart

Hinge Health, Inc (HNGE) is up 25.9% since the beginning of the year. At $58 per share, HNGE is trading 6.0% below its 52-week high of $62.


Loading charts...

S&P 500 Index

Returns By Period

Hinge Health, Inc (HNGE) has returned 25.90% so far this year and 44.57% over the past 12 months.


Hinge Health, Inc

1D
-4.01%
1M
28.73%
YTD
25.90%
6M
25.60%
1Y
44.57%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HNGE Monthly Returns History

Based on dividend-adjusted daily data since May 22, 2025, HNGE's average daily return is +0.25%, while the average monthly return is +4.57%. At this rate, an investment would double in approximately 1.3 years.

Historically, 57% of months were positive and 43% were negative. The best month was Jun 2025 with a return of +33.2%, while the worst month was Jan 2026 at -24.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 3 months.

On a daily basis, HNGE closed higher 52% of trading days. The best single day was Aug 6, 2025 with a return of +25.6%, while the worst single day was Nov 5, 2025 at -15.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-24.87%22.52%-9.82%15.66%26.03%4.04%25.90%
20253.41%33.24%-13.14%24.76%-12.48%1.39%-1.71%-5.03%23.67%

Benchmark Metrics

Hinge Health, Inc has an annualized alpha of 30.56%, beta of 1.39, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since May 23, 2025.

  • This stock captured 126.04% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -97.33%) - a profile typical of hedging or uncorrelated assets.
  • R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
30.56%
Beta
1.39
0.07
Upside Capture
126.04%
Downside Capture
-97.33%

Return for Risk

Risk / Return Rank

HNGE ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HNGE Risk / Return Rank: 6262
Overall Rank
HNGE Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
HNGE Sortino Ratio Rank: 6363
Sortino Ratio Rank
HNGE Omega Ratio Rank: 6262
Omega Ratio Rank
HNGE Calmar Ratio Rank: 6060
Calmar Ratio Rank
HNGE Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Hinge Health, Inc (HNGE) and compare them to S&P 500 Index.


HNGEBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.70

2.39

-1.69

Sortino ratio

Return per unit of downside risk

1.44

3.25

-1.81

Omega ratio

Gain probability vs. loss probability

1.18

1.43

-0.25

Calmar ratio

Return relative to maximum drawdown

0.92

3.11

-2.19

Martin ratio

Return relative to average drawdown

2.02

14.38

-12.36

Dividends

Dividend History


Hinge Health, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Hinge Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hinge Health, Inc was 48.52%, occurring on Feb 6, 2026. Recovery took 78 trading sessions.

The current Hinge Health, Inc drawdown is 4.01%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-48.52%Feb 2026
6mo 3d3mo 25d
9mo 28dAug 2025 - Jun 2026
2025 selloff2025
-17.28%Jun 2025
16d10d
26dMay 2025 - Jun 2025
2025 correction2025
-16.77%Jul 2025
6d1mo
1mo 6dJul 2025 - Aug 2025
2025 selloff2025
-5.09%Jun 2025
0s5d
5dJun 2025 - Jun 2025
2026 pullback2026
-4.01%Jun 2026
0s
2d 40mJun 2026 - now

Drawdown Indicators


HNGEBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-48.52%

-56.78%

+8.26%

Max Drawdown (1Y)

Largest decline over 1 year

-48.52%

-9.10%

-39.42%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-4.01%

0.00%

-4.01%

Average Drawdown

Average peak-to-trough decline

-18.79%

-10.72%

-8.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.13%

1.97%

+20.16%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hinge Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Hinge Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HNGE relative to other companies in the Health Information Services industry. Currently, HNGE has a P/S ratio of 7.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HNGE

Add Hinge Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HNGE